Die Rolle des Eye Movement Desensitization and Reprocessing (EMDR) bei Substanzgebrauchsstörungen: Ein systematischer Überblick

Zusammenfassung

Das Eye Movement Desensitization and Reprocessing (EMDR) ist eine therapeutische Methode, deren Wirksamkeit in der Behandlung von traumatischen Erkrankungen gezeigt werden konnte. Seit der Annahme eines spezifischen Suchtgedächtnisses bildet EMDR auch für Substanzgebrauchsstörungen einen eigenen Anwendungsbereich. Die vorliegende Überblicksarbeit fasst den aktuellen Forschungsstand zu EMDR-Behandlungseffekten bei stoffgebundenen Abhängigkeitserkrankungen zusammen. Mithilfe der Datenbanken PubMed und PsychInfo wurde eine systematische Literaturrecherche durchgeführt, wobei vier relevante Studien identifiziert wurden. Bei der Behandlung mit EMDR zeigte sich eine Reduktion des Cravings, der Angst und der Depressionswerte, sowie eine Verbesserung der Emotionsregulierung und des Selbstwertgefühls. Erste Ergebnisse verweisen auf das hohe therapeutische Potential von EMDR für den Bereich der Substanzgebrauchsstörungen

Abstract

Eye Movement Desensitization and Reprocessing (EMDR) is a therapeutic method that has been shown to be especially effective in traumatic disorders. Since the concept of an addiction memory has become widely accepted, the use of EMDR also in substance use disorders (SUD) treatment might count as a separate field. This review summarizes the current state of research on treatment effects EMDR in SUD. The literature search included the databases of PubMed and PsychInfo; four studies met the inclusion criteria. EMDR was found to be related to a decreased amount of craving, fear and depression and to an improvement of emotion regulation and management and self-esteem. Initial findings indicate a high therapeutic potential of EMDR in SUD treatment.

Schlüsselwörter

Abhängigkeit - EMDR - Neuro-kognitive Interventionen - Substanzgebrauchsstörungen - Systematischer Überblick

Key words

Addiction - EMDR - neuro-cognitive interventions - substance use disorder - systematic review

• Literatur

• 1 American Psychiatric Association. Practice guidelines for the treatment patients with acute stress disorder and posttraumatic stress disorder. Arlington, VA: Author; 2004
• 2 Lee CW, Taylor G, Drummond PD. The active ingredient in EMDR: Is it traditional exposure or dual focus of attention?. Clin. Psychol. Psychother. 2006; 13: 97-107
• 3 Sack M, Lempa W, Lamprecht F. Metaanalyse der Studien zur EMDR-Behandlung von Patienten mit posttraumatischen Belastungsstörungen – Der Einfluss der Studienqualität auf die Effektstärken -. PPmP – Psychother. · Psychosom. · Medizinische Psychol. [Internet]. 2001 51. 350-5 Available from: http: //www.thieme-connect.de/DOI/DOI?10.1055/s-2001-16898
• 4 Shapiro F. Efficacy of the eye movement desensitization procedure in the treatment of traumatic memories. J. Trauma. Stress 1989; 2: 199-223
• 5 Hofmann A. EMDR in Therapie psychotraumatischer Belastungssymptome. Stuttgart: Thieme; 1999
• 6 Antrobus JS, Antrobus JS, Singer JL. Eye movements accompanying daydreaming, visual imagery, and thought suppression. J. Abnorm. Soc. Psychol 69: 244-252
• 7 Shapiro F. Eye movement desensitization: A new treatment for post-traumatic stress disorder. J. Behav. Ther. Exp. Psy- chiatry 1989; 20: 211-7
• 8 Shapiro F. Alternative stimuli in the use of EMD(R). J. Behav. Ther. Exp. Psychiatry 1994; 25: 89
• 9 Shapiro F. Eye Movement Desensitization and Reprocessing: Basic principles, protocols, and procedures. New York: Guilford Press; 2001
• 10 Shapiro F. EMDR 12 years after its introduction: Past and future research. J. Clin. Psychol 2002; 58: 1-22
• 11 Stickgold R, Hobson Ja, Fosse R. et al. Sleep, learning, and dreams: off-line memory reprocessing. Science 2001; 294: 1052-7
• 12 Stickgold R. EMDR: A putative neurobiological mechanism of action. J. Clin. Psychol 2002; 58: 61-75
• 13 Gunter RW, Bodner GE. How eye movements affect unpleasant memories: Support for a working-memory account. Behav. Res. Ther 2008; 46: 913-31
• 14 Shapiro F. EMDR Eye Movement Desensitization and Reprocessing – Grundlagen und Praxis, Handbuch zur Behandlung traumatisierter Menschen. Paderborn: Junfermann; 1998
• 15 Schubbe O. Traumatherapie mit EMDR. Göttingen: Vandenhoeck & Ruprecht; 2015
• 16 Galley N, Hofmann A. Eye Movement Desensitization and Reprocessing (EMDR) als Behandlungsmethode bei psycho-traumatischen Hyper- und Amnesien. In: Calabrese P. editor Gedächtnis und Gedächtnisstörungen. Klin. Aspekte aus Forsch. und Praxis. Lengerich: Pabst Science Publishers; 1999. p. 217-40
• 17 Lee CW, Cuijpers P. A meta-analysis of the contribution of eye movements in processing emotional memories. J. Behav. Ther. Exp. Psychiatry 2013; 44
• 18 Heber R, Kellner M, Yehuda R. Salivary cortisol levels and the cortisol response to dexamethasone before and after EMDR: A case report. J. Clin. Psychol 2002; 58: 1521-30
• 19 Lansing K, Amen DG, Hanks C. et al. High–Resolution Brain SPECT Imaging and Eye Movement Desensitization and Reprocessing in Police Officers With PTSD. J. Neuropsychiatry Clin. Neurosci 2005; 17: 526-32
• 20 Lamprecht F. Spuren im Körper, Erinnerung und EMDR. Praxis der Traumatherapie. Stuttgart: Klett-Cotta; 2000
• 21 Hase M, Hofmann A. Risiken und Nebenwirkungen beim Einsatz der EMDR-Methode. PTT Persönlichkeitsstörungen Theor. und Prax 2005; 9: 16-21
• 22 Tesarz J, Leisner S, Gerhardt A. et al. Effects of Eye Movement Desensitization and Reprocessing (EMDR) Treatment in Chronic Pain Patients: A Systematic Review. Pain Med 2014; 15: 247-63
• 23 de Roos C, Veenstra A, de Jongh A. et al. Treatment of chronic phantom limb pain using a trauma-focused psychological approach. Pain Res Manag 2010; 15: 65-71
• 24 de Jongh A, ten Broeke E. Treatment of specific phobias with EMDR: Conceptualization and strategies for the selection of appropriate memories. J. EMDR Pract. Res 2007; 1: 46-56
• 25 de Roos C, de Jongh A. EMDR Treatment of Children and Adolescents With a Choking Phobia. J. EMDR Pract. Res 2008; 2: 201-11
• 26 Plassmann R, Seidel M. EMDR in der Gruppe bei Essstörungen. Das Ressourcenverankerungsprotokoll. Forum der Kinder- und Jugendpsychiatrie und Psychother 2003; 13: 33-45
• 27 Plassmann R. Im eigenen Rhythmus. Gießen: Psychosozial-Verlag; 2008
• 28 Shapiro F, Vogelmann-Sine S, Sine LF. Eye Movement Desensitization and Reprocessing: Treating Trauma and Substance Abuse. J. Psychoactive Drugs 1994; 26: 379-91
• 29 Vogelmann-Sine S. EMDR Chemical Dependency Treatment Manual. Honolulu, Hawaii: Author; 1998
• 30 Popky AJ. DeTUR, an Urge Reduction Protocol für Addictions and Dysfunctional Behaviors. In: Shapiro R. editor EMDR Solut. New York, London: Norton; 2005
• 31 Flik CE, de Roos C. Behandeling van fantoompijn met eye movement desensitisation and reprocessing (EMDR). Tijdschr. Psychiatr 2010; 52: 589-93
• 32 Schneider J, Hofmann A, Rost C. et al. EMDR in the treatment of chronic phantom limb pain. Pain Med 2008; 9: 76-82
• 33 Hase M, Schallmayer S, Sack M. EMDR Reprocessing of the Addiction Memory: Pretreatment, Posttreatment, and 1-Month Follow-Up. J. EMDR Pract. Res 2008; 2: 170-9
• 34 Littel M, Van Den Hout MA, Engelhard IM. Desensitizing addiction: Using eye movements to reduce the intensity of substance-related mental imagery and craving. Front. Psychiatry 2016; 7: 1-11
• 35 Perez-Dandieu B, Tapia G. Treating Trauma in Addiction with EMDR: A Pilot Study. J. Psychoactive Drugs 2014; 46: 303-9
• 36 Meysami-Bonab S, Abolghasemi A, Sheikhian M. et al. The Effectiveness of Eye Movement Desensitization and Reprocessing Therapy on the Emotion Regulation and Emotion Recognition of Addicted Individuals. Zahedan J. Res. Med. Sci 2012; 14: 33-7
• 37 Luber M. editor Eye Movement Desensitization and Reprocessing: EMDR Scripted Protocols and Summery sheets. New York: Springer Publishing Company; 2015
• 38 Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: A meta-analytic review. Clin. Psychol. Rev 2010; 30: 217-37
• 39 Trinidad DR, Unger JB, Chou CP. et al. The protective association of emotional intelligence with psychosocial smoking risk factors for adolescents. Pers. Individ. Dif 2004; 36: 945-54
• 40 Parker JDA, Taylor RN, Eastabrook JM. et al. Problem gambling in adolescence: Relationships with internet misuse, gaming abuse and emotional intelligence. Pers. Individ. Dif 2008; 45: 174-80
• 41 Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev 2008; 32: 777-810
• 42 Loree AM, Lundahl LH, Ledgerwood DM. Impulsivity as a predictor of treatment outcome in substance use disorders: Review and synthesis. Drug Alcohol Rev 2015; 34: 119-34
• 43 Shapiro F, Hofmann A. Einführungsseminar in die EMDR-Methode—Manual Teil 1 von 2. Watsonville, CA, & Bergisch-Gladbach: 1994
• 44 Feuerlein W, Ringer C, Kufner H. et al. The diagnosis of alcoholism—the Munich Alcoholism Test (MALT). Int. J. Rehabil. Res 1979; 2: 533-534
• 45 Magraf J. Diagnostisches Kurz-Inventar bei psychischen Störungen. Berlin: Springer; 1994
• 46 Eid J, Thayer JF, Johnsen BH. Measuring post-traumatic stress: a psychometric evaluation of symptom- and coping questionnaires based on a Norwegian sample. Scand. J. Psychol 1999; 40: 101-8
• 47 Bernstein EM, Putnam FW. Development, Reliability, and Validity of a Dissociation Scale. J. Nerv. Ment. Dis 1986; 174: 727-35
• 48 Nijenhuis ERS, Spinhoven P, van Dyck R. et al. The development of the somatoform dissociation questionnaire (SDQ-5) as a screening instrument for dissociative disorders. Acta Psychiatr. Scand 1997; 96: 311-8
• 49 Beck AT, Ward CH, Mendelson M. et al. An Inventory for Measuring Depression. Arch. Gen. Psychiatry 1961; 4: 561
• 50 Spielberger CD, Gorsuch RL, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970
• 51 Mann K, Ackermann K. Die OCDS-G: Psychometrische Kennwerte der deutschen Version der Obsessive Compulsive Drinking Scale. Sucht 2015; 46: 90-100
• 52 Garnefski N, Kraaij V, Spinhoven P. Negative life events, cognitive emotion regulation and emotional problems. Pers. Individ. Dif 2001; 30: 1311-27
• 53 Ekman P, Friesen W. Pictures of facial affect. Palo Alto, CA: Consulting Psychologists Press; 1976
• 54 Fagerstrom K-O, Schneider NG. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. J. Behav. Med 1989; 12: 159-82
• 55 Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res 2001; 3: 7-16
• 56 Cornil L. Formation Initiale à la Thérapie EMDR. Institut Français D’EMDR, Intégrativa; 2011
• 57 Weathers F, Litz B, Herman D. et al. The PTSD Checklist (PCL): Reliability, Validity, and Diagnostic Utility. Paper presented at the Annual Convention of the International Society for Traumatic Stress Studies, October 1993; San Antonio, TX: 1993
• 58 McLellan AT, Luborsky L, O’Brien CP. et al. An improved diagnostic instrument for substance abuse patients, The Addiction Severity Index. J. Nerv. Ment. Dis 1980; 168: 26-33
• 59 Coopersmith S. Self-Esteem Inventories. Palo Alto, CA: Consulting Psychologists Press; 1981
• 60 Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia scale—I. Item selection and cross-validation of the factor structure. J. Psychosom. Res 1994; 38: 23-32